Zurcher Kantonalbank (Zurich Cantonalbank) Precision Biosciences Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $32.8 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024
SELL
$0.29 - $0.45 $238 - $370
-824 Reduced 7.02%
10,916 $3,000
Q3 2023

Oct 25, 2023
SELL
$0.34 - $0.69 $315 - $641
-929 Reduced 7.33%
11,740 $3,000
Q4 2022

Feb 01, 2023
SELL
$0.97 - $45.0 $62 - $2,880
-64 Reduced 0.5%
12,669 $15,000
Q3 2022

Nov 09, 2022
SELL
$1.22 - $40.8 $189 - $6,324
-155 Reduced 1.2%
12,733 $17,000
Q2 2022

Aug 09, 2022
SELL
$1.15 - $3.34 $12,751 - $37,033
-11,088 Reduced 46.25%
12,888 $21,000
Q1 2022

Apr 21, 2022
SELL
$2.96 - $7.76 $13,571 - $35,579
-4,585 Reduced 16.05%
23,976 $74,000
Q4 2021

Feb 01, 2022
BUY
$7.4 - $11.66 $33,781 - $53,227
4,565 Added 19.02%
28,561 $211,000
Q3 2021

Nov 15, 2021
BUY
$9.18 - $14.15 $43,035 - $66,335
4,688 Added 24.28%
23,996 $277,000
Q2 2021

Jul 30, 2021
BUY
$8.07 - $12.52 $8,005 - $12,419
992 Added 5.42%
19,308 $242,000
Q1 2021

May 03, 2021
BUY
$8.57 - $15.79 $156,968 - $289,209
18,316 New
18,316 $190,000

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $539M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email